IQVIA Holdings Inc.

IQVIA is a global provider of clinical research services, commercial insights, and healthcare intelligence for the life sciences and healthcare industries. The company's solutions are powered by IQVIA Connected Intelligence™ to provide insights and services using health data, Healthcare-grade AI ®, advanced analytics, technology, and domain expertise. IQVIA uses AI responsibly, with capabilities built on approaches to privacy, regulatory compliance, and patient safety, delivering AI to industry standards of trust, scalability, and precision. The company has approximately 93,000 employees in over 100 countries, including experts in healthcare, life sciences, data science, technology, and operational excellence. IQVIA protects individual patient privacy using privacy-enhancing technologies and safeguards while generating and analyzing information to help healthcare stakeholders identify disease patterns and correlate with treatment paths and therapy. Its insights and execution capabilities assist biotech, medical device, and pharmaceutical companies, medical researchers, government agencies, payers, and other healthcare stakeholders in understanding diseases, human behaviors, and scientific advances. IQVIA possesses one of the largest collections of healthcare information globally, including sales, prescription, promotional, social media, medical claims, electronic medical records, and genomics data, with over 1.2 billion comprehensive, longitudinal, unique non-identified patient records. This information set contains approximately 68 petabytes of unique proprietary data from approximately 150,000 data suppliers and covering over one million data feeds globally. Based on this data, IQVIA delivers information and insights on approximately 90% of the world's pharmaceuticals, as measured by 2024 sales. The company standardizes, curates, structures, and integrates this information using sophisticated analytics and its global technology infrastructure.